SPTX Seaport Therapeutics, Inc.
$23.34▲ +0.26%
Healthcare
Other
After hours
$23.34▲ +0.00%
Sep 11, 4:10 PM ET
Volume 134.2K
Avg Volume (10D) 147.0K
Key Metrics & Fundamentals
Market Cap
$1.25B
P/E Ratio
–
Div Yield
–%
52W Range
14.85 - 28.38
% vs 50 MA
4.11%
% vs 200 MA
–%
RSI-14
49.1
MACD Histogram
-0.3500
Beta (1Y vs SPY)
0.78
Free Cash Flow
-$20.17M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$27.19M
COGS
–
Operating Exp
$27.54M
Operating Income
-$27.54M
EBIT
-$27.54M
Pretax Income
-$24.89M
Net Income
-$25.41M
EPS (Diluted)
-0.48
Price & Volume History
Loading chart…
Recent News
PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
Business Wire · Sep 9, 2026 5:13 PM
Sector Update: Healthcare Stocks Mixed Premarket Wednesday
MT Newswires · Sep 9, 2026 1:16 PM
Seaport Therapeutics Says GlyphAllo Shows no Next-Morning Driving Impairment in Phase 1 Trial
MT Newswires · Sep 9, 2026 11:54 AM
Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
Business Wire · Sep 9, 2026 11:00 AM
Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference
Business Wire · Aug 31, 2026 11:00 AM
Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls
The Fly · Aug 26, 2026 1:41 PM
Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO
24/7 Wall St. · Aug 20, 2026 2:40 PM
Seaport Therapeutics' Q2 Loss Per Share Narrows
MT Newswires · Aug 3, 2026 11:23 AM
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Business Wire · Aug 3, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SPTX's money flow as a full page
Social Sentiment
No Reddit posts found for SPTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.